State Street’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

State Street’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-85,538	Closed	-$115K	–	4974
2021 Q4	$115K	Sell	85,538 -17,865	-17%	-$42.2K	﹤0.01%	4548
2021 Q3	$301K	Sell	103,403 -21,735	-17%	-$72.3K	﹤0.01%	4197
2021 Q2	$437K	Sell	125,138 -255,980	-67%	-$879K	﹤0.01%	3909
2021 Q1	$1.3M	Buy	381,118 +118,202	+45%	+$2.23M	﹤0.01%	3568
2020 Q4	$5.05M	Buy	262,916 +14,254	+6%	+$220K	﹤0.01%	2954
2020 Q3	$3.34M	Buy	248,662 +1,481	+0.6%	+$42K	﹤0.01%	2983
2020 Q2	$10.5M	Buy	247,181 +27,716	+13%	+$897K	﹤0.01%	2393
2020 Q1	$6.06M	Sell	219,465 -21,353	-9%	-$623K	﹤0.01%	2531
2019 Q4	$7.82M	Buy	240,818 +34,707	+17%	+$1.08M	﹤0.01%	2642
2019 Q3	$5.37M	Buy	206,111 +65,344	+46%	+$2.19M	﹤0.01%	2751
2019 Q2	$5.17M	Buy	140,767 +31,406	+29%	+$753K	﹤0.01%	2804
2019 Q1	$2.42M	Buy	109,361 +3,727	+4%	+$65.2K	﹤0.01%	3078
2018 Q4	$1.49M	Sell	105,634 -10,657	-9%	-$166K	﹤0.01%	3229
2018 Q3	$2.26M	Buy	116,291 +17,801	+18%	+$363K	﹤0.01%	3204
2018 Q2	$2.17M	Buy	98,490 +7,533	+8%	+$176K	﹤0.01%	3222
2018 Q1	$1.93M	Buy	+90,957	New	+$2.15M	﹤0.01%	3185

Other funds holding ODT

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

State Street's ODT Position: Q1 2022 in Review

State Street sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 85,538 shares — an estimated $115K sold.

State Street first reported a position in ODT in Q1 2018 and held it in 16 quarters. The position peaked at $10.5M in Q2 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

State Street reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
State Street sold 85,538 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $115K.
State Street first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
State Street's Odonate Therapeutics, Inc. Common Stock position peaked at $10.5M in Q2 2020.
8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on State Street's 13F filing for Q1 2022, filed 16 May 2022.